Septal panniculitis: Difference between revisions
From WikiMD's Medical Encyclopedia
CSV import |
CSV import |
||
| Line 1: | Line 1: | ||
{{Infobox medical condition | |||
| name = Septal panniculitis | |||
| synonyms = | |||
| specialty = [[Dermatology]] | |||
| symptoms = [[Erythema]], [[tenderness]], [[nodules]] | |||
| complications = | |||
| onset = | |||
| duration = | |||
| causes = [[Inflammation]] of the [[subcutaneous fat]] | |||
| risks = | |||
| diagnosis = [[Clinical examination]], [[biopsy]] | |||
| differential = [[Erythema nodosum]], [[Lobular panniculitis]] | |||
| treatment = [[Nonsteroidal anti-inflammatory drugs|NSAIDs]], [[corticosteroids]] | |||
| medication = | |||
| prognosis = | |||
| frequency = | |||
| deaths = | |||
}} | |||
'''Septal Panniculitis''' is a type of [[panniculitis]] that primarily affects the septa within the subcutaneous fat layer. This condition is characterized by inflammation of the septa, the fibrous partitions that separate the lobules of fat in the subcutaneous tissue. Septal panniculitis can lead to various clinical manifestations, including tender skin nodules and systemic symptoms in more severe cases. It is important to differentiate septal panniculitis from lobular panniculitis, as the treatment and prognosis may differ. | '''Septal Panniculitis''' is a type of [[panniculitis]] that primarily affects the septa within the subcutaneous fat layer. This condition is characterized by inflammation of the septa, the fibrous partitions that separate the lobules of fat in the subcutaneous tissue. Septal panniculitis can lead to various clinical manifestations, including tender skin nodules and systemic symptoms in more severe cases. It is important to differentiate septal panniculitis from lobular panniculitis, as the treatment and prognosis may differ. | ||
==Etiology== | ==Etiology== | ||
The exact cause of septal panniculitis is often idiopathic, meaning it arises without a known cause. However, it can be associated with underlying conditions such as: | The exact cause of septal panniculitis is often idiopathic, meaning it arises without a known cause. However, it can be associated with underlying conditions such as: | ||
| Line 6: | Line 24: | ||
* [[Sarcoidosis]], a systemic condition that can present with septal panniculitis among its cutaneous manifestations. | * [[Sarcoidosis]], a systemic condition that can present with septal panniculitis among its cutaneous manifestations. | ||
* [[Lupus panniculitis]] (Lupus profundus), associated with systemic lupus erythematosus, affecting the deeper layers of the skin. | * [[Lupus panniculitis]] (Lupus profundus), associated with systemic lupus erythematosus, affecting the deeper layers of the skin. | ||
==Clinical Presentation== | ==Clinical Presentation== | ||
Patients with septal panniculitis typically present with: | Patients with septal panniculitis typically present with: | ||
* Erythematous, tender nodules, primarily located on the lower legs, though they can appear on any part of the body. | * Erythematous, tender nodules, primarily located on the lower legs, though they can appear on any part of the body. | ||
* Systemic symptoms such as fever, malaise, and joint pain may accompany the skin manifestations, especially in erythema nodosum. | * Systemic symptoms such as fever, malaise, and joint pain may accompany the skin manifestations, especially in erythema nodosum. | ||
==Diagnosis== | ==Diagnosis== | ||
Diagnosis of septal panniculitis involves a combination of clinical evaluation and histopathological examination. A biopsy of the affected tissue is crucial for distinguishing septal from lobular panniculitis. Histologically, septal panniculitis shows inflammation confined to the septa without involvement of the fat lobules. | Diagnosis of septal panniculitis involves a combination of clinical evaluation and histopathological examination. A biopsy of the affected tissue is crucial for distinguishing septal from lobular panniculitis. Histologically, septal panniculitis shows inflammation confined to the septa without involvement of the fat lobules. | ||
==Treatment== | ==Treatment== | ||
Treatment of septal panniculitis focuses on managing the underlying cause, if identified, and symptomatic relief. Options include: | Treatment of septal panniculitis focuses on managing the underlying cause, if identified, and symptomatic relief. Options include: | ||
| Line 21: | Line 36: | ||
* Potassium iodide and colchicine are also used in the treatment of erythema nodosum. | * Potassium iodide and colchicine are also used in the treatment of erythema nodosum. | ||
* Management of any underlying conditions, such as antibiotics for infections or specific therapies for autoimmune diseases. | * Management of any underlying conditions, such as antibiotics for infections or specific therapies for autoimmune diseases. | ||
==Prognosis== | ==Prognosis== | ||
The prognosis for septal panniculitis is generally good, especially in cases of erythema nodosum, which often resolves without long-term complications. However, the outcome can vary depending on the underlying cause and the presence of associated systemic diseases. | The prognosis for septal panniculitis is generally good, especially in cases of erythema nodosum, which often resolves without long-term complications. However, the outcome can vary depending on the underlying cause and the presence of associated systemic diseases. | ||
==See Also== | ==See Also== | ||
* [[Panniculitis]] | * [[Panniculitis]] | ||
| Line 30: | Line 43: | ||
* [[Sarcoidosis]] | * [[Sarcoidosis]] | ||
* [[Systemic Lupus Erythematosus]] | * [[Systemic Lupus Erythematosus]] | ||
[[Category:Dermatology]] | [[Category:Dermatology]] | ||
[[Category:Inflammatory diseases]] | [[Category:Inflammatory diseases]] | ||
[[Category:Autoimmune diseases]] | [[Category:Autoimmune diseases]] | ||
{{Medicine-stub}} | {{Medicine-stub}} | ||
Latest revision as of 23:21, 3 April 2025
| Septal panniculitis | |
|---|---|
| Synonyms | |
| Pronounce | N/A |
| Specialty | Dermatology |
| Symptoms | Erythema, tenderness, nodules |
| Complications | |
| Onset | |
| Duration | |
| Types | N/A |
| Causes | Inflammation of the subcutaneous fat |
| Risks | |
| Diagnosis | Clinical examination, biopsy |
| Differential diagnosis | Erythema nodosum, Lobular panniculitis |
| Prevention | N/A |
| Treatment | NSAIDs, corticosteroids |
| Medication | |
| Prognosis | |
| Frequency | |
| Deaths | |
Septal Panniculitis is a type of panniculitis that primarily affects the septa within the subcutaneous fat layer. This condition is characterized by inflammation of the septa, the fibrous partitions that separate the lobules of fat in the subcutaneous tissue. Septal panniculitis can lead to various clinical manifestations, including tender skin nodules and systemic symptoms in more severe cases. It is important to differentiate septal panniculitis from lobular panniculitis, as the treatment and prognosis may differ.
Etiology[edit]
The exact cause of septal panniculitis is often idiopathic, meaning it arises without a known cause. However, it can be associated with underlying conditions such as:
- Erythema nodosum, the most common form of septal panniculitis, which is often related to infections, medications, or autoimmune diseases.
- Sarcoidosis, a systemic condition that can present with septal panniculitis among its cutaneous manifestations.
- Lupus panniculitis (Lupus profundus), associated with systemic lupus erythematosus, affecting the deeper layers of the skin.
Clinical Presentation[edit]
Patients with septal panniculitis typically present with:
- Erythematous, tender nodules, primarily located on the lower legs, though they can appear on any part of the body.
- Systemic symptoms such as fever, malaise, and joint pain may accompany the skin manifestations, especially in erythema nodosum.
Diagnosis[edit]
Diagnosis of septal panniculitis involves a combination of clinical evaluation and histopathological examination. A biopsy of the affected tissue is crucial for distinguishing septal from lobular panniculitis. Histologically, septal panniculitis shows inflammation confined to the septa without involvement of the fat lobules.
Treatment[edit]
Treatment of septal panniculitis focuses on managing the underlying cause, if identified, and symptomatic relief. Options include:
- Nonsteroidal anti-inflammatory drugs (NSAIDs) for pain and inflammation.
- Corticosteroids, either topically or systemically, to reduce inflammation.
- Potassium iodide and colchicine are also used in the treatment of erythema nodosum.
- Management of any underlying conditions, such as antibiotics for infections or specific therapies for autoimmune diseases.
Prognosis[edit]
The prognosis for septal panniculitis is generally good, especially in cases of erythema nodosum, which often resolves without long-term complications. However, the outcome can vary depending on the underlying cause and the presence of associated systemic diseases.
See Also[edit]
